Paper6445875
Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats.
Sen S and 2 others. Hypertension, 1980. Cited by 213 papers, by iCite.
Cite this record
ConductScience Library. Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Papers, record 6445875. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6445875
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Captopril | Major topic |
| Cardiomegaly | Major topic |
| Hypertension | Major topic |
| Proline | Major topic |
| Animals | |
| Male | |
| Organ Size | |
| Rats | |
| Renin |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 213 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36498725 | Interventricular Septum Thickness for the Prediction of Coronary Heart Disease and Myocardial Infarction in Hypertension Population: A Prospective Study. | J Clin Med | 2022 | https://conductscience.org/library/papers/36498725 | PubMed |
| 23604708 | A low-carbohydrate/high-fat diet reduces blood pressure in spontaneously hypertensive rats without deleterious changes in insulin resistance. | Am J Physiol Heart Circ Physiol | 2013 | https://conductscience.org/library/papers/23604708 | PubMed |
| 9711055 | [The renin-angiotensin system in cardiovascular diseases]. | Med Klin (Munich) | 1998 | https://conductscience.org/library/papers/9711055 | PubMed |
| 8460511 | Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials? | West J Med | 1993 | https://conductscience.org/library/papers/8460511 | PubMed |
| 8177233 | Role of extracellular matrix proteins in heart function. | Mol Cell Biochem | 1993 | https://conductscience.org/library/papers/8177233 | PubMed |
| 7582472 | Prevention by blockade of angiotensin subtype1-receptors of the development of genetic hypertension but not its heritability. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/7582472 | PubMed |
| 7009133 | Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. | Drugs | 1980 | https://conductscience.org/library/papers/7009133 | PubMed |
| 6357337 | Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. | Br J Pharmacol | 1983 | https://conductscience.org/library/papers/6357337 | PubMed |
| 6227633 | Myocardial hydroxyproline and mechanical response to prolonged pressure loading followed by unloading in the cat. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6227633 | PubMed |
| 6212929 | Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6212929 | PubMed |
| 3718425 | Renal hypertensive hypertrophy in the rat: a substrate for arrhythmogenicity. | Basic Res Cardiol | 1986 | https://conductscience.org/library/papers/3718425 | PubMed |
| 2978605 | The connective tissue and contractile response of the myocardium to the development and regression of hypertrophy. | Trans Am Clin Climatol Assoc | 1989 | https://conductscience.org/library/papers/2978605 | PubMed |
| 2975216 | Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review. | Drugs | 1988 | https://conductscience.org/library/papers/2975216 | PubMed |
| 2969799 | Comparison between the effects of urapidil and methyldopa on left ventricular hypertrophy and haemodynamics in humans. | Drugs | 1988 | https://conductscience.org/library/papers/2969799 | PubMed |
| 2969798 | Effects of different antihypertensive drugs on left ventricular function. | Drugs | 1988 | https://conductscience.org/library/papers/2969798 | PubMed |
| 2937765 | Biochemical aspects of salt-induced, pressure-independent left ventricular hypertrophy in rats. | Heart Vessels | 1985 | https://conductscience.org/library/papers/2937765 | PubMed |
| 2690905 | Angiotensin and the remodelling of the myocardium. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2690905 | PubMed |
| 2669728 | Effects of captopril on left ventricular structure and function in SHR with established hypertension. | Basic Res Cardiol | 1989 | https://conductscience.org/library/papers/2669728 | PubMed |
| 2535055 | Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass. | Cardiovasc Drugs Ther | 1989 | https://conductscience.org/library/papers/2535055 | PubMed |
| 2533076 | Regression of left ventricular hypertrophy on long-term treatment with captopril of severe hypertensives refractory to standard triple treatment. | Eur J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2533076 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6445875
GET https://conductscience.org/api/papers/v1/6445875/cited_by?page=2